JPMorgan Starts BioNTech (BNTX) at Overweight
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $92.30 +0.20%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Cory Kasimov initiates coverage on BioNTech (NASDAQ: BNTX) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
